Antimicrobial evaluation and docking study of some new substituted benzimidazole-2yl derivatives.

Benzimidazoles incorporated biologically active heterocycles such as quinoline, triazine-3-thione, thiazole and thiadiazole, were synthesized utilizing 2-acetylbenzimidazole as a building block. The structures of the newly synthesized benzimidazoles were assured by their spectral data (IR, H NMR, C- NMR and MS spectra). Most of the synthesized candidates were screened for their in vitro antimicrobial activity against Staphylococcus aureus, Escherichia coli, Bacillus pumilus and antifungal activity against (Saccharomyces cerevisiae). As a result, 2-(2-(1-(1H-benzo[d]imidazol-2-yl)ethylidene)hydrazineyl)-5-(furan-2-yl)-1,3,4-thiadiazole (14) had the most potent inhibitory activity against all tested bacteria with no antifungal inhibition. Furthermore, to gain insight into the mode of action of the synthesized compounds as antibacterial agents, docking studies were performed for the synthesized compounds in order to evaluate their activity as anti-bacterial agents. Virtual screening of the most promising compounds was performed against two bacterial proteins (DNA gyrase subunit B, and penicillin binding protein 1a) that are known targets for some antibiotics.